FDA Issues Safety Warning for Heart Rhythm Drug Multaq

Posted on Dec 30, 2011
According to a report from the Injury Board, the heart rhythm drug, Multaq, has been issued a safety warning by the U.S. Food and Drug Administration (FDA).

Multaq (dronedarone) was approved in 2009 for the treatment of atrial fibrillation and atrial flutter. Both of these heart conditions increase the risk of stroke and death. However, the very drug that is meant to treat the heart has been found to cause serious or fatal cardiovascular problems.

New safety warnings have been placed on the box, indicating that it should be used only in the short-term and that it doubles the risk of users suffering heart-related complications.

Additionally, the label provides instructions to physicians that at least every 3 months, the patients’ heart rhythm should be checked. If atrial fibrillation continues to be an issue, Multaq should no longer be used. Other medical treatment may need to replace it.

If you or a loved one has suffered serious or fatal complications after using a medication, you could be entitled to compensation. To learn what your rights are and who may be held liable for your injuries, it would be in your best interest to seek counsel from a Louisville medication error attorney.

Contacting a Louisville Medication Error Attorney

A Louisville medication error attorney at Gray and White can help you handle every aspect of your Kentucky medication error claim. If you’ve become the victim of a medication error in Kentucky, contact us today for a free evaluation of your case – 888-450-4456 or 502-210- 8942.
Matthew L. White
Connect with me
Founder & Partner of Louisville Personal Injury Law Firm Gray & White Law